In a new study, researchers from @MGHCancerCenter @broadinstitute and colleagues investigated why breast #cancer therapy tamoxifen may lead to higher risk of uterine cancer.
Read more: https://t.co/Jdd6mt19c0 https://t.co/x4WaWEBOzI @getz_lab
On #WorldLungCancerDay, we focus on BSF-supported U.S.–Israel research tackling one of cancer’s toughest challenges: persister cells.
Dr. Yaara Oren @TelAvivUni & Dr. Gad Getz @broadinstitute are uncovering how these elusive cells survive therapy - and how we might stop them.
1/ 🧵Check out our new study in @NatureGenet, which examines how precancerous conditions (MGUS/SMM) evolve into Multiple Myeloma, and offers new computational methods to predict progression risk and model cancer evolution.
https://t.co/IHnN87QKTk
Excited to share our comprehensive cell line atlas for biliary tract cancer (BTC) in collab with Dr. Nabeel Bardeesy @MGHCancerCenter & @DrFranVazquez, and led by @Vindhya_Vijay & Negin Karisani! https://t.co/ifDaogY4zE @CancerDepMap@CD_AACR
Also see: https://t.co/6zvHg38On9
Spread the word! Registration for the "Mutations in Time and Space" conference is open. The meeting is all about the origins, patterns, and consequences of mutations across cells, individuals, populations, species. Abstract submission deadline: Jan 17th https://t.co/KMEHdXnLMQ...
Very happy and excited to announce that I'll be starting my own research group at @emblebi! The group will focus on lineage tracing, somatic evolution and the origins of cancer. Interested in doing a postdoc in the group or know someone who is? Please reach out!
With @rheinbay_lab and additional Broad collaborators, we are excited to enter into this partnership with @Inocras to analyze whole genomes for the benefit of cancer research and cancer patients 🧬! @GenomeDoctor@BroadInstitute @MGHCancerCenter
Six leading scientists and longtime members of the Broad community have been named as new core institute members at Broad: @getz_lab, @AnnaGreka, Nir Hacohen, @macosko, @bmneale, and @pardissabeti Congratulations to all! https://t.co/bYnMpmTrEL
Excited to present at #FOGBoston tomorrow on making @UltimaGenomics turnkey compatible with all existing downstream tools, with a real-world example leveraging methodology developed here in the @getz_lab to infer cancer phylogenies at resolutions not possible without #WGS.
“As someone who’s been rowing for a pretty long time, I think it’s really important to have a balance between two things that you find value in.” Learn how computational biologist @lizd0m juggles research and life as an elite rower in a #WhyIScience Q&A: https://t.co/YCCyPiwmXQ
Thank you so much to the @broadinstitute#WhyIScience team for sharing my experiences as both an elite rower and a computational biologist! The balance isn’t always easy, but it’s always been worth it.
Our own @GeffenYifat is featured this month as the #NCIProteomics Spotlight on Early-Career Investigators Series for her wonderful work in the Clinical Proteomic Tumor Analysis Consortium #CPTAC 👏🎉! Check out her interview in the link below. @BroadInstitute@theNCI
Big news was announced in the KCS this morning: Please join us in welcoming Dr. Paul Bryce to the KCS and to @umasslowell. Paul will be joining the KCS on May 1 as our Associate Dean for Research & Graduate Studies. Welcome to the team! @brycelab
https://t.co/Ymdl3QFxDC